
iCE Neurosystems is a medical technology company focused on revolutionizing brain care for critically-ill patients through its integrated, continuous EEG system platform called iCEWav. The platform enables early identification and treatment of brain injuries by providing high-fidelity, long-term continuous EEG monitoring with easy setup and interpretation, designed for use by routine clinical personnel without specialized EEG technical skills. The system integrates brain and physiological data with clinical decision support applications to assist clinicians in real-time neurological activity monitoring in intensive care, emergency, and surgical settings. iCE Neurosystems has received FDA 510(k) clearance for its devices and has been recognized by the American Heart Association and MedTech Innovator, indicating strong market traction and validation. The company aims to improve patient outcomes, reduce brain injury, and lower healthcare costs by enabling proactive brain monitoring and intervention.

iCE Neurosystems is a medical technology company focused on revolutionizing brain care for critically-ill patients through its integrated, continuous EEG system platform called iCEWav. The platform enables early identification and treatment of brain injuries by providing high-fidelity, long-term continuous EEG monitoring with easy setup and interpretation, designed for use by routine clinical personnel without specialized EEG technical skills. The system integrates brain and physiological data with clinical decision support applications to assist clinicians in real-time neurological activity monitoring in intensive care, emergency, and surgical settings. iCE Neurosystems has received FDA 510(k) clearance for its devices and has been recognized by the American Heart Association and MedTech Innovator, indicating strong market traction and validation. The company aims to improve patient outcomes, reduce brain injury, and lower healthcare costs by enabling proactive brain monitoring and intervention.
Product: iCEWav continuous EEG neuromonitoring platform with subcutaneous iCE‑SG electrode and analytics
Regulatory: FDA 510(k) clearance for iCEWav (Mar 2020) and iCE‑SG electrode (May 2021)
Headquarters: Washington, D.C.
Founded: 2017
Recent support: Non-equity assistance announced May 29, 2024 (MedTech Innovator)
Continuous brain monitoring and neurological injury detection in critical care
2017
Medical devices / Neurotechnology
$2.95M
Part of reported total of ~$4.5M raised by April 2021
Announced non-equity assistance to the company
“MedTech Innovator participation/assistance in 2024”